RYALTRIS
Google image searchProduct monograph
Active ingredients
olopatadine hydrochloride, 665 MCG/ACT
mometasone furoate (mometasone furoate monohydrate), 25 MCG/ACT
DIN: 02531186
Dosage form(s): SPRAY, METERED DOSE
Route(s) of administration: NASAL
Description: SUSPENSION
Schedule: Prescription
Company: GLENMARK SPECIALTY SA
Date: 17-MAR-2023
ATC:
- R01 — NASAL PREPARATIONS (ATC, ATC/DDD, )
- R01A — DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (ATC, ATC/DDD)
- R01AD — Corticosteroids (ATC, ATC/DDD)
- R01AD59 — MOMETASONE, COMBINATIONS (ATC/DDD)
